Department of Biomedical and Clinical Sciences ''Luigi Sacco'', University of Milan, ASST Fatebenefratelli Sacco, Milan, Italy. RATIONALE: Primary angioedema is defined as an angioedema occurring in absence of wheals and of a causative factor. Aim of the study is to define frequency and clinical features of patients with non hereditary primary angiodema and normal C1 inhibitor seen at our outpatient clinic from January 2015 to December 2017. METHODS: Angioedema patients classified according to Hawk 2014 criteria, were considered. C1 inhibitor deficient patients, hereditary angioedema with normal C1 inhibitor and angioedema related to ACE inhibitor were excluded. Specific analysis was restricted to idiopathic histaminergic and non histaminergic acquired angioedema (IH-AAE and InH-AAE). RESULTS: Of a total of 788 patients evaluated at our outpatient angioedema clinic, 76 (10%) fullfilled the inclusion criteria: 65 (86%) were classified as IH-AAE (46% CR, 38% PR, 11% on demand treatment, 5% unknown) and 11 (14%) as InH-AAE. Females were 54%, median age 50 years. Overall 87% had recurrent attacks without differences between IH-AAE and InH-AAE. In 62% IH-AAE-patients attacks were recurrent and treated with anti-histamines. The localization of attacks in the IH-AAE was 86% neck/face, 37% cutaneous peripheral, 38% oral cavity/larynx, 5% abdominal. The PRs vs CRs reported a trend toward a higher frequency (96% vs 76%, p50.06) of localization to neck/face and a lower frequency (50% vs 24%, p50.06) of peripheral. CONCLUSIONS: Among acquired angioedema, idiopathic histaminergic forms are highly more frequent. Management of primary angioedema constitutes 10% of ambulatory activity, mainly addressed to IH-AAE. A marked proportion of IH-AAE response to anti-histamine is partial suggesting that histamine is just one of the mediator.
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